Re:The Same Pill That Costs $1,000 in America Sells for $4 i...
by replicatorblog on Wednesday December 30, 2015 @12:57AM
(#10810965)
Exactly—please point to a pharma company that is doing original R&D and creating important products in a country where IP protections are weak.
[ Parent
| on HN ]
Re:The Same Pill That Costs $1,000 in America Sells for $4 i...
by aravindet on Wednesday December 30, 2015 @01:12AM
(#10811001)
This is the correlation-causation confusion again. Some countries have big pharma companies, others don't. Big pharma companies can spend more on research as well as on lobbying to maintain over-the-top “IP” protections.
The flaw in your reasoning is seeing the presence or absence of IP protection as an independent variable, and level of R&D as a function of that. I think both are dependent on the amount of cash pharma companies have to spend.